- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04846049
Inter-Disciplinary Outpatient Care Model Providing Comprehensive Geriatric Assessment, Care-Coordination & Co-management (C4)
An Inter-Disciplinary Outpatient Care Model Providing Comprehensive Geriatric Assessment, Care-Coordination and Co-management to High Need High Risk Veterans Meeting HBPC Criteria
The Department of Veterans Affairs' (VA) Home Based Primary Care (HBPC) program provides comprehensive care to its sickest, frailest Veterans with multiple complex chronic diseases. The HBPC program is a resource intensive non-institutional care program where Veterans, who are not able to receive primary care at the VA, are closely monitored and care is provided using an interdisciplinary team that coordinates the care through multi-professional home visits.
The Geriatric Extended Care recommended that Miami Veteran Affairs Healthcare System (VAHS) HBPC enroll from a list of over 2,000 pre-identified High Need High Risk (HNHR) Miami Veterans for whom HBPC enrollment would have a high likelihood of clinical and economic benefits. HNHR Veterans have the greatest need for care but face the steepest challenges with access. However, despite best of intentions, the Miami HBPC program does not have the capacity to enroll the large numbers of Veterans on this new HNHR list. Therefore, innovative strategies are needed to provide appropriate needed care for this HNHR Veteran population.
Goal: Maintain older Veterans in their homes for as long as possible.
Aims: Design and pilot test an evidence-based, outpatient, Comprehensive geriatric assessment, Care plan based, Care-coordination, Co-management (C4) model, for 100 HBPC eligible HNHR older Veterans who are not enrolled in the HBPC program.
The investigators will develop, implement and evaluate a VA model to provide a comprehensive geriatric assessment of HNHR Veterans, design a structured care plan that includes care coordination to link their needs to appropriate referrals, home and community based services, monitor and coach patients and caregivers, and coordinate their care across VA and non-VA providers and settings.
Objectives:
- Characterize the needs of the HNHR group of Veterans
- Evaluate the feasibility and processes of the Geri C4 model
- Evaluate the impact of the model on patient, healthcare utilization, and other Geriatric Extended Care (GEC) outcomes
- Determine the facilitators and barriers for implementing the intervention
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
The intervention will consist of the following components:
- Comprehensive Geriatric Assessment: A complete geriatric assessment using an interdisciplinary team (geriatrician, psychologist, social worker, dietitian, and nurse). The investigators will increase the number of geriatrician and interdisciplinary team visits to every other month interspersed with their primary care visits.
- Care Planning: The investigators will review and discuss each participant during the interdisciplinary team meeting. The team will jointly generate a care plan for the implementation of the interventions. The care plan will be shared with the respective primary care provider.
- Care Coordination: Participant/caregiver will be regularly contacted to confirm that the care plan is being implemented and to allow the participant/caregiver to discuss issues related to the management.
- Co-management: Primary care provider and project Geriatricians will share responsibility and decision making for participants aiming to prevent and treat geriatric complications.
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiesteder
-
-
Florida
-
Miami, Florida, Forenede Stater, 33125
- Miami VA Healthcare System
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Hospitalization in prior 12-months
- Received post-acute care in prior 12-months (skilled nursing facility or skilled home health care)
- Two or more chronic conditions
- Two or more activity of daily living impairments or greater or equal to six Frailty Index score
- Less than or equal to 60 minutes of closest VA primary care site.
Exclusion Criteria:
- Enrolled in Home Based Primary Care
- Using hospice Care
- Using palliative care
- In a foster home
- In a nursing home
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Comprehensive Care
Veterans with complex medical conditions that may need more help. This intervention will provide extra care coordination after a complete assessment of their health. Research team will assess veteran's memory, physical function, strength, balance, and from there, find the areas they need the most help with and coordinate services at home. This is in addition to their regular primary care provider. |
|
Standard Care
Veterans receiving standard of care
|
No intervention or treatment will be provided.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Changes in FRAIL score
Tidsramme: 5 minutes
|
The FRAIL scale (Fatigue, Resistance, Ambulation, Illnesses, & Loss of Weight) is a simple questionnaire of frailty syndrome for older adults.
If a patient scores 3-5 points over a total score of 5 points in the FRAIL, the patient is considered as frail.
Change from baseline score and 6 months.
|
5 minutes
|
Change in Montreal Cognitive Assessment (MOCA)
Tidsramme: 10 minutes
|
Rapid screen of cognitive abilities designed to detect mild cognitive dysfunction consisting of 16 items and 11 categories assessing multiple cognitive domains.
No cognitive impairment >=25 Mild cognitive impairment = 20-24 Severe cognitive impairment < 20.
Change from baseline score and 6 months.
|
10 minutes
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Katz Index of Independence in Activities of Daily Living
Tidsramme: 10 minutes
|
Assessment of activities of daily living.
Change from baseline score and 6 months.
|
10 minutes
|
Lawton-Brody Instrumental Activities of Daily Living Scale
Tidsramme: 10 minutes
|
Instrumental activities of daily living assessment.
Change from baseline score and 6 months.
|
10 minutes
|
Detection of symptoms of depression
Tidsramme: 5 minutes
|
Patient Health Questionnaire (PHQ-2 and PHQ-9) for depression.
The PHQ 2 is a preliminary screening tool administered before the PHQ 9.
If a patient responds 'yes´ to one or both questions on the PHQ-2, the PHQ-9 questions are administered.
Cut-off is set to a score of ≥ 2 PHQ-2.
PHQ-9 scoring: 0-4 none-minimal; 5-9 mild;10-14 moderate; 15-19 moderately severe; 20-27 severe.
|
5 minutes
|
Change in number of clinic visits
Tidsramme: 6-months
|
Changes in pre intervention number of clinic visits.
This will be measure by survey and chart review.
|
6-months
|
Change in number of hospital admissions
Tidsramme: 6-months
|
Changes in pre intervention number of hospital admissions.
This will be measure by survey and chart review.
|
6-months
|
Change in healthcare utilization
Tidsramme: 6-months
|
Changes in pre intervention number of Home and Community Based services in place.
This will be measure by survey and chart review.
|
6-months
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Stuti Dang, MD,MPH, Miami VA Healthcare System
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 1208331-1
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Geriatrisk vurdering
-
Wake Forest University Health SciencesAfsluttetSelf Geriatric Assessment Measure (SGAM)Forenede Stater
-
AdventHealthAfsluttetDudoenoscope Assessment ToolForenede Stater
-
Edwards LifesciencesAfsluttetHjerteoutput og Preload Assessment | LungevandsvurderingTyskland, Schweiz
-
University of Southern CaliforniaAfsluttetTotal Body Water AssessmentForenede Stater
-
Bradford Teaching Hospitals NHS Foundation TrustUkendtBeslagsfejlfrekvens | Limningstid pr. beslag | Adhæsive Remnant Index for Type of Bond Failure | Behandlingens længde | Peer Assessment Rating
Kliniske forsøg med Comprehensive Care
-
Chunrui LiNanjing IASO Biotechnology Co., LtdRekrutteringPlasmacelleleukæmi | Recidiverende/Refraktær MyelomKina
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityAfsluttetRefraktært diffust stort B-cellet lymfomKina
-
Nexcella Inc.Ikke rekrutterer endnuLet kæde (AL) amyloidoseForenede Stater
-
Second Affiliated Hospital, School of Medicine,...RekrutteringRecidiverende og refraktær B-celle lymfomKina
-
Second Affiliated Hospital, School of Medicine,...Rekruttering
-
University of California, San FranciscoTrukket tilbageLymfom | Leukæmi | Plasmacelledyskrasi
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Trukket tilbageAkut lymfatisk leukæmi | Non-hodgkin lymfomForenede Stater
-
Nanjing IASO Biotechnology Co., Ltd.Ruijin HospitalRekrutteringPlasmacelleleukæmi | Recidiverende/Refraktær MyelomKina
-
Hebei Senlang Biotechnology Inc., Ltd.RekrutteringLymfom | Myelomatose | Akut lymfatisk leukæmiKina
-
Fuda Cancer Hospital, GuangzhouTrukket tilbageCAR-T celle immunterapi | Hjernegliom